Table of Contents

• Laurence Kennedy,
• William H. Herman,
• Poul Strange,
• and Anthony Harris

Impact of Active Versus Usual Algorithmic Titration of Basal Insulin and Point-of-Care Versus Laboratory Measurement of HbA_1c on Glycemic Control in Patients With Type 2 Diabetes : The Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial

L.K. has served on advisory boards for sanofi-aventis and has received honoraria from sanofi-aventis, Pfizer, GlaxoSmithKline, Novo Nordisk, Takeda, and Eli Lilly. W.H.H. has received honoraria and consulting fees from Aventis Pharmaceuticals.

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

• Gerard X. Brogan, Jr,
• Eric D. Peterson,
• Jyotsna Mulgund,
• Deepak L. Bhatt,
• E. Magnus Ohman,
• W. Brian Gibler,
• Charles V. Pollack, Jr,
• Michael E. Farkouh,
• and Matthew T. Roe

Treatment Disparities in the Care of Patients With and Without Diabetes Presenting With Non–ST-Segment Elevation Acute Coronary Syndromes

• Donald Garrow and
• Leonard E. Egede

Association Between Complementary and Alternative Medicine Use, Preventive Care Practices, and Use of Conventional Medical Services Among Adults With Diabetes

The Effects of Aerobic Exercise on Glucose and Counterregulatory Hormone Concentrations in Children With Type 1 Diabetes

• Leonard E. Egede and
• Yvonne Michel

Medical Mistrust, Diabetes Self-Management, and Glycemic Control in an Indigent Population With Type 2 Diabetes

• Olga Kordonouri,
• Reinhard Hartmann,
• Renate Lauterborn,
• Christine Barnekow,
• Julia Hoeffe,
• and Dorothee Deiss

Age-Specific Advantages of Continuous Subcutaneous Insulin Infusion as Compared With Multiple Daily Injections in Pediatric Patients: One-year follow-up comparison by matched-pair analysis

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.

• G. Stennis Watson,
• Mark A. Reger,
• Laura D. Baker,
• Marguerite J. McNeely,
• Wilfred Y. Fujimoto,
• Steven E. Kahn,
• Edward J. Boyko,
• Donna L. Leonetti,
• and Suzanne Craft

Effects of Exercise and Nutrition on Memory in Japanese Americans With Impaired Glucose Tolerance

• Eric J. Brunner,
• Martin J. Shipley,
• Daniel R. Witte,
• John H. Fuller,
• and Michael G. Marmot

Relation Between Blood Glucose and Coronary Mortality Over 33 Years in the Whitehall Study

• Gillian L. Booth,
• Moira K. Kapral,
• Kinwah Fung,
• and Jack V. Tu

Recent Trends in Cardiovascular Complications Among Men and Women With and Without Diabetes

• Jacqueline T. Jonker,
• Chris De Laet,
• Oscar H. Franco,
• Anna Peeters,
• Johan Mackenbach,
• and Wilma J. Nusselder

Physical Activity and Life Expectancy With and Without Diabetes: Life table analysis of the Framingham Heart Study

• Satish Garg,
• Howard Zisser,
• Sherwyn Schwartz,
• Timothy Bailey,
• Roy Kaplan,
• Samuel Ellis,
• and Lois Jovanovic

Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor: A randomized controlled trial

S.G. serves on an advisory board for and has received research support from DexCom. L.J. serves on an advisory panel for and has received research support from DexCom.

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

• Riccardo Calafiore,
• Giuseppe Basta,
• Giovanni Luca,
• Angelo Lemmi,
• M. Pia Montanucci,
• Giuseppe Calabrese,
• Leda Racanicchi,
• Francesca Mancuso,
• and Paolo Brunetti

Microencapsulated Pancreatic Islet Allografts Into Nonimmunosuppressed Patients With Type 1 Diabetes: First two cases

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.

• SoJung Lee,
• Fida Bacha,
• Neslihan Gungor,
• and Silva A. Arslanian

Racial Differences in Adiponectin in Youth: Relationship to visceral fat and insulin sensitivityv

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

• Ravi Retnakaran,
• Bernard Zinman,
• Philip W. Connelly,
• Mathew Sermer,
• and Anthony J.G. Hanley

Impaired Glucose Tolerance of Pregnancy Is a Heterogeneous Metabolic Disorder as Defined by the Glycemic Response to the Oral Glucose Tolerance Test

• Howard Zisser,
• Lois Jovanovic,
• Ashley Thorsell,
• Asher Kupperman,
• Larisa J Taylor,
• Paulina Ospina,
• and Mosha Hod

The Fidgety Fetus Hypothesis: Fetal activity is an additional variable in determining birth weight of offspring of women with diabetes

• Vera Bril and
• Robert A. Buchanan

Long-Term Effects of Ranirestat (AS-3201) on Peripheral Nerve Function in Patients With Diabetic Sensorimotor Polyneuropathy

• Gabriel Manjarrez,
• Rocio Herrera,
• Monica Leon,
• and Jorge Hernandez-R

A Low Brain Serotonergic Neurotransmission in Children With Type 1 Diabetes Detected Through the Intensity Dependence of Auditory-Evoked Potentials

• Mark E. Molitch,
• Demetra Rupp,
• and Mercedes Carnethon

Higher Levels of HDL Cholesterol Are Associated With a Decreased Likelihood of Albuminuria in Patients With Long-Standing Type 1 Diabetes

• Tri Q. Nguyen,
• Lise Tarnow,
• Steen Andersen,
• Peter Hovind,
• Hans-Henrik Parving,
• Roel Goldschmeding,
• and Frans A. van Nieuwenhoven

Urinary Connective Tissue Growth Factor Excretion Correlates With Clinical Markers of Renal Disease in a Large Population of Type 1 Diabetic Patients With Diabetic Nephropathy

• Gottfried Rudofsky, Jr,
• Antonia Schroedter,
• Andreas Schlotterer,
• Olga E. Voron’ko,
• Martin Schlimme,
• Joerg Tafel,
• Berend H. Isermann,
• Per M. Humpert,
• Michael Morcos,
• Angelika Bierhaus,
• Peter P. Nawroth,
• and Andreas Hamann

Functional Polymorphisms of UCP2 and UCP3 Are Associated With a Reduced Prevalence of Diabetic Neuropathy in Patients With Type 1 Diabetes

• Roldano Scognamiglio,
• Christian Negut,
• Saula Vigili de Kreutzenberg,
• Antonio Tiengo,
• and Angelo Avogaro

Effects of Different Insulin Regimes on Postprandial Myocardial Perfusion Defects in Type 2 Diabetic Patients

• Kazuaki Nishio,
• Masayuki Sakurai,
• Taro Kusuyama,
• Meiei Shigemitsu,
• Tomoyasu Fukui,
• Kitaro Kawamura,
• Seiji Itoh,
• Noburu Konno,
• and Takashi Katagiri

A Randomized Comparison of Pioglitazone to Inhibit Restenosis After Coronary Stenting in Patients With Type 2 Diabetes

• Emmanuel Cosson,
• Isabelle Pham,
• Paul Valensi,
• Jacques Pariès,
• Jean-Raymond Attali,
• and Alain Nitenberg

Impaired Coronary Endothelium–Dependent Vasodilation Is Associated With Microalbuminuria in Patients With Type 2 Diabetes and Angiographically Normal Coronary Arteries

• Yoshiyuki Hattori,
• Sachiko Hattori,
• and Kikuo Kasai

Globular Adiponectin Activates Nuclear Factor–κB in Vascular Endothelial Cells, Which in Turn Induces Expression of Proinflammatory and Adhesion Molecule Genes

• Takuma Narita,
• Mihoko Hosoba,
• Masafumi Kakei,
• and Seiki Ito

Increased Urinary Excretions of Immunoglobulin G, Ceruloplasmin, and Transferrin Predict Development of Microalbuminuria in Patients With Type 2 Diabetes

• Manel Pladevall,
• Bonita Singal,
• L. Keoki Williams,
• Carlos Brotons,
• Heidi Guyer,
• Josep Sadurni,
• Carles Falces,
• Manuel Serrano-Rios,
• Rafael Gabriel,
• Jonathan E. Shaw,
• Paul Z. Zimmet,
• and Steven Haffner

A Single Factor Underlies the Metabolic Syndrome: A confirmatory factor analysis

Additional information for this article can be found in an online appendix at http://care.diabetesjournals.org.

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.

• Lynn E. Eberly,
• Ronald Prineas,
• Jerome D. Cohen,
• Gabriela Vazquez,
• Xin Zhi,
• James D. Neaton,
• and Lewis H. Kuller

Metabolic Syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial

• Hirohito Sone,
• Sachiko Tanaka,
• Shun Ishibashi,
• Yoshimitsu Yamasaki,
• Shinichi Oikawa,
• Hideki Ito,
• Yasushi Saito,
• Yasuo Ohashi,
• Yasuo Akanuma,
• and Nobuhiro Yamada

The New Worldwide Definition of Metabolic Syndrome Is Not a Better Diagnostic Predictor of Cardiovascular Disease in Japanese Diabetic Patients Than the Existing Definitions: Additional analysis from the Japan Diabetes Complications Study *

Members of the JDCS Study Group have been listed previously ().

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

• Carlos Lahoz,
• Ignacio Vicente,
• Fernando Laguna,
• María F. García-Iglesias,
• Manuel Taboada,
• and Jose M. Mostaza

Metabolic Syndrome and Asymptomatic Peripheral Artery Disease in Subjects Over 60 Years of Age

• Henry S. Kahn

The Lipid Accumulation Product Is Better Than BMI for Identifying Diabetes: A population-based comparison

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

• David M. Kendall

Thiazolidinediones: The case for early use

D.M.K. serves on an advisory panel for Takeda Pharmaceuticals, Eli Lilly, and Bristol-Myers Squibb. The International Diabetes Center has received honoraria and proceeds from Takeda Pharmaceuticals, Eli Lilly, Bristol-Myers Squibb, GlaxoSmithKline, and Aventis.

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

• William T. Cefalu,
• Steven R. Smith,
• Lawrence Blonde,
• and Vivian Fonseca

The Hurricane Katrina Aftermath and Its Impact on Diabetes Care: Observations from “ground zero”: lessons in disaster preparedness of people with diabetes

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

• Zachary. T Bloomgarden

Developments in Diabetes and Insulin Resistance

• Mayer B. Davidson

The Last of the 9th

• Hanady M. Sharabash,
• Tami L. Remington,
• Peter Mar,
• Ralph Winston,
• and Paul C. Walker

Retrospective Review of Metformin in Inpatients and Outpatients at the University of Michigan

• Hubertus Himmerich,
• Stephany Fulda,
• Ludwig Schaaf,
• Pierre A. Beitinger,
• Andreas Schuld,
• and Thomas Pollmächer

Changes in Weight and Glucose Tolerance During Treatment With Mirtazapine

• Salma M Wakil,
• Khalid Al-Rubeaan,
• Osama Alsmadi,
• Faiqa Imtiaz,
• Pamela Carroll,
• Mohammed Rajab,
• Shaden Al-Katari,
• Mohammed Al-Katari,
• and Brian F. Meyer

The Peroxisome Proliferator–Activated Receptor-γ2 P12A Polymorphism and Type 2 Diabetes in an Arab Population

• Yoko Kikumoto,
• Jun Wada,
• and Hirofumi Makino

The Application of Synthetic hANP in Diabetic Nephropathy With Nephrotic Syndrome

• Péter Doró,
• Ria Benkő,
• Mária Matuz,
• and Gyöngyvér Soós

Seasonality in the Incidence of Type 2 Diabetes: A population-based study

• David J. Di Cesar,
• Robert Ploutz-Snyder,
• Ruth S. Weinstock,
• and Arnold M. Moses

Vitamin D Deficiency Is More Common in Type 2 Than in Type 1 Diabetes

• Christian Herder,
• Jens Baumert,
• Hubert Kolb,
• Wolfgang Koenig,
• Stephan Martin,
• and Barbara Thorand

Circulating Levels of Interleukin-18 Independent of Body Fat and Fat-Free Mass: Results from the MONICA/KORA study

• Dario Giugliano and
• Katherine Esposito

The Metabolic Syndrome: Time for a Critical Appraisal: Joint Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Kahn et al.

• Leslie Citrome,
• Richard I.G. Holt,
• and Timothy G. Dinan

The Metabolic Syndrome: Time for a Critical Appraisal: Joint Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Kahn et al.

• Dan Mircea Cheţa

The Metabolic Syndrome: Time for a Critical Appraisal: Joint Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Kahn et al.

• Bruce M. Psaty,
• Thomas Lumley,
• and Curt D. Furberg

The Metabolic Syndrome: Time for a Critical Appraisal: Joint Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Kahn et al.

• Richard Kahn,
• John Buse,
• Ele Ferrannini,
• and Michael Stern

The Metabolic Syndrome: Time for a Critical Appraisal: Joint Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Citrome et al., Giugliano and Esposito, Cheţa, and Psaty et al.

• Einar Stefánsson

The Case for Biennial Retinopathy Screening in Children and Adolescents: Response to Maguire et al.

• Ann M. Maguire,
• Janine M. Cusumano,
• Maria E. Craig,
• and Kim C. Donaghue

The Case for Biennial Retinopathy Screening in Children and Adolescents: Response to Stefánsson

• Marc Creus,
• Wolfgang Vogel,
• and Heinz Zoller

Of Genes and Men: The Alternative View of Sex Differences in Cystic Fibrosis: Response to Sims et al. and Milla et al.

• Carlos E. Milla,
• Joanne Billings,
• and Antoinette Moran

Of Genes and Men: The Alternative View of Sex Differences in Cystic Fibrosis: Response to Creus et al.

• Erika J. Sims,
• Jonathan McCormick,
• and Anil Mehta

Of Genes and Men: The Alternative View of Sex Differences in Cystic Fibrosis: Response to Creus et al.

• Jochen G. Schneider,
• Maximilian von Eynatten,
• Stephan Schiekofer,
• Peter P. Nawroth,
• and Klaus A. Dugi

Low Plasma Adiponectin Levels Are Associated With Increased Hepatic Lipase Activity In Vivo: Response to Kobayashi et al.

• Junji Kobayashi,
• Yuko Murase,
• Masa-aki Kawashiri,
• Atsushi Nohara,
• Akihiro Inazu,
• and Hiroshi Mabuchi

Low Plasma Adiponectin Levels Are Associated With Increased Hepatic Lipase Activity In Vivo: Response to Schneider et al.

• Boris Draznin

Karl Sussman, MD